THE USE OF POSITRON EMISSION TOMOGRAPHY IN THE CLINICAL-ASSESSMENT OF EPILEPSY

被引:21
|
作者
CHUGANI, HT
机构
[1] LAB NUCL MED,LOS ANGELES,CA
[2] UNIV CALIF LOS ANGELES,SCH MED,DEPT RADIOL SCI,DIV NUCL MED,LOS ANGELES,CA 90024
[3] UNIV CALIF LOS ANGELES,SCH MED,DEPT PEDIAT,LOS ANGELES,CA 90024
[4] UNIV CALIF LOS ANGELES,SCH MED,DEPT NEUROL,LOS ANGELES,CA 90024
关键词
D O I
10.1016/S0001-2998(05)80119-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Positron emission tomography (PET) of local cerebral glucose utilization is highly sensitive in detecting epileptogenic regions that correspond to electrographic localization in pateints with epilepsy. In medically refractory temporal lobe epilepsy for which surgical resection of the epileptogenic zone is a therapeutic option, the application of PET enables more than 50% of adults and older children to be successfully operated on without the necessity for chronic intracranial electrographic monitoring. In infants with intractable infantile spasms and various types of partial epilepsy, PET has uncovered focal areas of cortical dysplasia and other anatomic abnormalities, which, after resection, have resulted in cessation of seizures and developmental improvement. The distribution of PET abnormality is in excellent agreement with the extent of the epileptogenic zone as determined by intraoperative electrocorticography, thus avoiding the necessity for chronic intracranial electrographic monitoring in 90% of these infants. As a result of PET, the preoperative evaluation of intractable epilepsy in both adults and children has become less invasive and less costly. © 1991 W.B. Saunders Company. All rights reserved.
引用
收藏
页码:247 / 253
页数:7
相关论文
共 50 条
  • [31] Trends in use of positron emission tomography
    Tashiro, M
    Kubota, K
    Itoh, M
    Moser, E
    LANCET, 2001, 357 (9259): : 886 - 886
  • [32] Use of positron emission tomography in sarcoidosis
    Bonardel, G.
    Carmoi, T.
    Gontier, E.
    Lecoules, S.
    Cambon, A.
    Foehrenbach, H.
    Algayres, J. -P.
    REVUE DE MEDECINE INTERNE, 2011, 32 (02): : 101 - 108
  • [33] Positron emission tomography in clinical oncology
    Foehrenbach, H
    Albérini, JL
    Maszelin, P
    Bonardel, G
    Tenenbaum, F
    de Dreuille, O
    Richard, B
    Gaillard, JF
    Devaux, JY
    PRESSE MEDICALE, 2003, 32 (06): : 276 - 283
  • [34] Ranking of positron emission tomography (PET) in epilepsy diagnostics
    Koepp, MJ
    Hammers, A
    KLINISCHE NEUROPHYSIOLOGIE, 2003, 34 (04) : 176 - 181
  • [35] Atlas of Clinical Positron Emission Tomography
    Nall, Colleen M.
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2006, 34 (04) : 235 - 235
  • [36] The use of positron emission tomography in hepatology
    Shiomi, S
    HEPATOLOGY RESEARCH, 2005, 31 (02) : 63 - 68
  • [37] POSITRON EMISSION TOMOGRAPHY - TECHNOLOGY AND USE
    HICHWA, RD
    MEDICAL PHYSICS, 1987, 14 (03) : 506 - 506
  • [38] CLINICAL POSITRON EMISSION TOMOGRAPHY IMAGING
    HOFFMAN, JM
    HANSON, MW
    COLEMAN, RE
    RADIOLOGIC CLINICS OF NORTH AMERICA, 1993, 31 (04) : 935 - 959
  • [39] Positron emission tomography in clinical neurology
    Herholz, K
    Heiss, WD
    MOLECULAR IMAGING AND BIOLOGY, 2004, 6 (04) : 239 - 269
  • [40] POSITRON EMISSION TOMOGRAPHY IN CLINICAL MANAGEMENT
    COLEMAN, RE
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1995, 165 (04) : 1006 - 1007